NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|61742775|ref|NP_787116|]
View 

leucyl-cystinyl aminopeptidase isoform 2 [Homo sapiens]

Protein Classification

M1 family metallopeptidase( domain architecture ID 10176184)

M1 family metallopeptidase containing an ERAP1-like C-terminal domain with HEAT-like repeats is a zinc-dependent metallopeptidase with an HEXXH motif as part of its active site, similar to aminopeptidase N, a broad specificity aminopeptidase, and glutamyl aminopeptidase, which releases N-terminal glutamate from a peptide

EC:  3.4.11.-
Gene Ontology:  GO:0008237|GO:0008270|GO:0006508
MEROPS:  M1

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
161-598 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


:

Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 619.60  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  161 LRYELSLHPNLTSMTFRGSVTISVQALQVTWNIILHSTGHNISRVTFMSAVSSQEKQAEILEYAYHGQIAIVAPEALLAG 240
Cdd:cd09601    1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETLPPG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  241 HNYTLKIEYSANISSSYYGFYGFSYTDESNEKKYFAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNMPKK 320
Cdd:cd09601   81 ENYTLSIEFTGKLNDDLRGFYRSSYTDEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMPPV 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  321 SSVVLDDGLVQDEFSESVKMSTYLVAFIVGEMKNLS-QDVNGTLVSIYAVPEKIGQVHYALETTVKLLEFFQNYFEIQYP 399
Cdd:cd09601  161 ESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIEsTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIPYP 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  400 LKKLDLVAIPDFEAGAMENWGLLTFREETLLYDSNTSSMADRKLVTKIIAHELAHQWFGNLVTMKWWNDLWLNEGFATFM 479
Cdd:cd09601  241 LPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATYM 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  480 EYFSLEKIFKELSSYEDFL-DARFKTMKKDSLNSSHPISSSVQSSEQIEEMFDSLSYFKGSSLLLMLKTYLSEDVFQHAV 558
Cdd:cd09601  321 EYLAVDKLFPEWNMWDQFVvDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRKGL 400
                        410       420       430       440
                 ....*....|....*....|....*....|....*....|..
gi 61742775  559 VLYLHNHSYASIQSDDLWDSFNEVTN--QTLDVKRMMKTWTL 598
Cdd:cd09601  401 RKYLKKHAYGNATTDDLWEALQEASGesKPLDVKEIMDSWTL 442
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
675-995 2.19e-76

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


:

Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 253.35  E-value: 2.19e-76
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    675 WVKVNINMNGYYIVHYADDDWEALIHQLkiNPYVLSDKDRANLINNIFELAGLGKVPLKRAFDLINYLGNENHTAPITEA 754
Cdd:pfam11838    1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    755 LFQTDLIYNLLEklgYMDLASRLVTRVFKLLQNQIQQQTWTDEG--TPSMRELRSALLEFACTHNLGNCSTTAMKLFDDW 832
Cdd:pfam11838   79 LSQLSTLRSLLS---ADPEYEALKAFLRKLLSPLAEKLGWEAPPgeSHLDRQLRALLLSAACSAGDPECVAEAKKLFDAW 155
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    833 MasNGTQSLPTDVMTTVFKVGAK--TDKGWSFLLGKYISIGSEAEKNKILEALASSEDVRKLYWLMKSSLNGDNFRTQKL 910
Cdd:pfam11838  156 L--DGDDAIPPDLRWAVYCAAVAngGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDL 233
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    911 SFIIRTVGRHFPGHLLAWDFVKENWNKLVQKFPLGSyTIQNIVAGSTYLFSTKTHLSEVQAFFENQSEATFRlRCVQEAL 990
Cdd:pfam11838  234 RAVIAGLASNPAGRDLAWDFVKENWDALVKRLGGGS-SLGRLVKGLTPSFSTEEELDEVEAFFADKDTPGLR-RALAQAL 311

                   ....*
gi 61742775    991 EVIQL 995
Cdd:pfam11838  312 ETIRR 316
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
161-598 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 619.60  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  161 LRYELSLHPNLTSMTFRGSVTISVQALQVTWNIILHSTGHNISRVTFMSAVSSQEKQAEILEYAYHGQIAIVAPEALLAG 240
Cdd:cd09601    1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETLPPG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  241 HNYTLKIEYSANISSSYYGFYGFSYTDESNEKKYFAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNMPKK 320
Cdd:cd09601   81 ENYTLSIEFTGKLNDDLRGFYRSSYTDEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMPPV 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  321 SSVVLDDGLVQDEFSESVKMSTYLVAFIVGEMKNLS-QDVNGTLVSIYAVPEKIGQVHYALETTVKLLEFFQNYFEIQYP 399
Cdd:cd09601  161 ESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIEsTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIPYP 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  400 LKKLDLVAIPDFEAGAMENWGLLTFREETLLYDSNTSSMADRKLVTKIIAHELAHQWFGNLVTMKWWNDLWLNEGFATFM 479
Cdd:cd09601  241 LPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATYM 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  480 EYFSLEKIFKELSSYEDFL-DARFKTMKKDSLNSSHPISSSVQSSEQIEEMFDSLSYFKGSSLLLMLKTYLSEDVFQHAV 558
Cdd:cd09601  321 EYLAVDKLFPEWNMWDQFVvDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRKGL 400
                        410       420       430       440
                 ....*....|....*....|....*....|....*....|..
gi 61742775  559 VLYLHNHSYASIQSDDLWDSFNEVTN--QTLDVKRMMKTWTL 598
Cdd:cd09601  401 RKYLKKHAYGNATTDDLWEALQEASGesKPLDVKEIMDSWTL 442
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
153-678 4.60e-126

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 396.32  E-value: 4.60e-126
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  153 RLPTAVVPLRYELSLHPNLTSMTFRGSVTISVQALQVTWN-IILHSTGHNISRVTfmsaVSSQEkqaeiLEYAYHGQ-IA 230
Cdd:COG0308   10 YRPPGYDVTHYDLDLDLDPATTRLSGTATITFTATEAPLDsLVLDLKGLEVTSVT----VDGKP-----LDFTRDGErLT 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  231 IVAPEALLAGHNYTLKIEYSANISSSYYGFYGFSYTDEsneKKYFAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQ 310
Cdd:COG0308   81 ITLPKPLAPGETFTLEIEYSGKPSNGGEGLYRSGDPPD---GPPYLYTQCEPEGARRWFPCFDHPDDKATFTLTVTVPAG 157
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  311 YTALSNMPKKSSVVLDDGLVQDEFSESVKMSTYLVAFIVGEMKNLSQD-VNGTLVSIYAVPEKIGQVHYALETTVKLLEF 389
Cdd:COG0308  158 WVAVSNGNLVSETELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTfASGVPLRVYVRPGLADKAKEAFESTKRMLDF 237
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  390 FQNYFEIQYPLKKLDLVAIPDFEAGAMENWGLLTFREeTLLYDSnTSSMADRKLVTKIIAHELAHQWFGNLVTMKWWNDL 469
Cdd:COG0308  238 FEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGE-KVLADE-TATDADYERRESVIAHELAHQWFGNLVTCADWDDL 315
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  470 WLNEGFATFMEYFSLEKIFKelssyEDFLDARFKTMKK------DSLNSSHPIssSVQSSEQIEEMFDSLSYFKGSSLLL 543
Cdd:COG0308  316 WLNEGFATYMEQLFSEDLYG-----KDAADRIFVGALRsyafaeDAGPNAHPI--RPDDYPEIENFFDGIVYEKGALVLH 388
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  544 MLKTYLSEDVFQHAVVLYLHNHSYASIQSDDLWDSFNEVTNQtlDVKRMMKTWTLQKGFPLVTVQ-----KKGKELFIQQ 618
Cdd:COG0308  389 MLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEASGR--DLSAFFDQWLYQAGLPTLEVEyeydaDGKVTLTLRQ 466
                        490       500       510       520       530       540
                 ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 61742775  619 ERFFlnmkpeiqpsdtSYLWHIPLSY-VTEGRnysKYQSVSLLDKKSGVInlTEEVLWVKV 678
Cdd:COG0308  467 TPPR------------PHPFHIPLEVgLLGGK---LTARTVLLDGEQTEL--VAKPDPVLL 510
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
378-596 4.40e-105

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 326.55  E-value: 4.40e-105
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    378 YALETTVKLLEFFQNYFEIQYPLKKLDLVAIPDFEAGAMENWGLLTFREETLLYDSNTSSMADRKLVTKIIAHELAHQWF 457
Cdd:pfam01433    1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    458 GNLVTMKWWNDLWLNEGFATFMEYFSLEKIFKELSSYEDF-LDARFKTMKKDSLNSSHPISSSVQSSEQIEEMFDSLSYF 536
Cdd:pfam01433   81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQFlLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                          170       180       190       200       210       220
                   ....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    537 KGSSLLLMLKTYLSEDVFQHAVVLYLHNHSYASIQSDDLWDSFNEVTNqTLDVKRMMKTW 596
Cdd:pfam01433  161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASG-PLDVDSFMDTW 219
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
675-995 2.19e-76

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 253.35  E-value: 2.19e-76
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    675 WVKVNINMNGYYIVHYADDDWEALIHQLkiNPYVLSDKDRANLINNIFELAGLGKVPLKRAFDLINYLGNENHTAPITEA 754
Cdd:pfam11838    1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    755 LFQTDLIYNLLEklgYMDLASRLVTRVFKLLQNQIQQQTWTDEG--TPSMRELRSALLEFACTHNLGNCSTTAMKLFDDW 832
Cdd:pfam11838   79 LSQLSTLRSLLS---ADPEYEALKAFLRKLLSPLAEKLGWEAPPgeSHLDRQLRALLLSAACSAGDPECVAEAKKLFDAW 155
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    833 MasNGTQSLPTDVMTTVFKVGAK--TDKGWSFLLGKYISIGSEAEKNKILEALASSEDVRKLYWLMKSSLNGDNFRTQKL 910
Cdd:pfam11838  156 L--DGDDAIPPDLRWAVYCAAVAngGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDL 233
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    911 SFIIRTVGRHFPGHLLAWDFVKENWNKLVQKFPLGSyTIQNIVAGSTYLFSTKTHLSEVQAFFENQSEATFRlRCVQEAL 990
Cdd:pfam11838  234 RAVIAGLASNPAGRDLAWDFVKENWDALVKRLGGGS-SLGRLVKGLTPSFSTEEELDEVEAFFADKDTPGLR-RALAQAL 311

                   ....*
gi 61742775    991 EVIQL 995
Cdd:pfam11838  312 ETIRR 316
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
216-588 1.02e-71

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 255.10  E-value: 1.02e-71
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    216 KQAEILEYAYHGQIAI--------VAPEALLAGHNyTLKIEYSANISSSYYGFYGFsyTDESNEKKYfAATQFEPLAARS 287
Cdd:TIGR02412   56 LAAQIESVTLNGILDVapvydgsrIPLPGLLTGEN-TLRVEATRAYTNTGEGLHRF--VDPVDGEVY-LYTQFEPADARR 131
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    288 AFPCFDEPAFKATFIIKIIRDEQYTALSNMPKKSSVVLDDGLVQdEFSESVKMSTYLVAFIVGEMKNLSQDVNGTLVSIY 367
Cdd:TIGR02412  132 VFAVFDQPDLKANFKFSVKAPEDWTVISNSRETDVTPEPADRRW-EFPETPKLSTYLTAVAAGPYHSVQDESRSYPLGIY 210
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    368 AVPEKIGQVH--YALETTVKLLEFFQNYFEIQYPLKKLDLVAIPDFEAGAMENWGLLTFREETLLYDSNTSsmADRKLVT 445
Cdd:TIGR02412  211 ARRSLAQYLDadAIFTITRQGLAFFHRKFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAENFLHRAEATR--AEKENRA 288
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    446 KIIAHELAHQWFGNLVTMKWWNDLWLNEGFATFMEYFSLEkifkELSSYEDFLDARFKTMK-----KDSLNSSHPISSSV 520
Cdd:TIGR02412  289 GVILHEMAHMWFGDLVTMRWWNDLWLNESFAEYMGTLASA----EATEYTDAWTTFAAQGKqwayeADQLPTTHPIVADV 364
                          330       340       350       360       370       380
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 61742775    521 QSSEQIEEMFDSLSYFKGSSLLLMLKTYLSEDVFQHAVVLYLHNHSYASIQSDDLWDSFNEVTNQTLD 588
Cdd:TIGR02412  365 ADLADALSNFDGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHAFGNATLDDLIDSLAKASGRDLS 432
pepN PRK14015
aminopeptidase N; Provisional
366-608 3.41e-07

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 54.37  E-value: 3.41e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775   366 IYAVPEKIGQVHYALETtvklleffqnyfeiqypLKK--------------LDL---VAIPDFEAGAMENWGLLTFREET 428
Cdd:PRK14015  218 IYVEPGNLDKCDHAMDS-----------------LKKsmkwdeerfgleydLDIfmiVAVDDFNMGAMENKGLNIFNSKY 280
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775   429 LLYDSNTSSMADRKLVTKIIAHELAHQWFGNLVTMKWWNDLWLNEGFATF--------MEYFSLEKIfkelssyED--FL 498
Cdd:PRK14015  281 VLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGLTVFrdqefsadLGSRAVKRI-------EDvrVL 353
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775   499 DAR-FktmKKDSLNSSHPIS-SSVQsseqieEM--FDSLS-YFKGSSLLLMLKTYLSEDVFQHAVVLYLHNH--SYASIq 571
Cdd:PRK14015  354 RAAqF---AEDAGPMAHPVRpDSYI------EInnFYTATvYEKGAEVIRMLHTLLGEEGFRKGMDLYFERHdgQAVTC- 423
                         250       260       270
                  ....*....|....*....|....*....|....*..
gi 61742775   572 sDDLWDSFNEVTNQTLDVkrmMKTWTLQKGFPLVTVQ 608
Cdd:PRK14015  424 -EDFVAAMEDASGRDLSQ---FRRWYSQAGTPRVTVS 456
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
161-598 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 619.60  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  161 LRYELSLHPNLTSMTFRGSVTISVQALQVTWNIILHSTGHNISRVTFMSAVSSQEKQAEILEYAYHGQIAIVAPEALLAG 240
Cdd:cd09601    1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGSGIIEVTVVTDEETEFLTITLDETLPPG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  241 HNYTLKIEYSANISSSYYGFYGFSYTDESNEKKYFAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNMPKK 320
Cdd:cd09601   81 ENYTLSIEFTGKLNDDLRGFYRSSYTDEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMPPV 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  321 SSVVLDDGLVQDEFSESVKMSTYLVAFIVGEMKNLS-QDVNGTLVSIYAVPEKIGQVHYALETTVKLLEFFQNYFEIQYP 399
Cdd:cd09601  161 ESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIEsTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIPYP 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  400 LKKLDLVAIPDFEAGAMENWGLLTFREETLLYDSNTSSMADRKLVTKIIAHELAHQWFGNLVTMKWWNDLWLNEGFATFM 479
Cdd:cd09601  241 LPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATYM 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  480 EYFSLEKIFKELSSYEDFL-DARFKTMKKDSLNSSHPISSSVQSSEQIEEMFDSLSYFKGSSLLLMLKTYLSEDVFQHAV 558
Cdd:cd09601  321 EYLAVDKLFPEWNMWDQFVvDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRKGL 400
                        410       420       430       440
                 ....*....|....*....|....*....|....*....|..
gi 61742775  559 VLYLHNHSYASIQSDDLWDSFNEVTN--QTLDVKRMMKTWTL 598
Cdd:cd09601  401 RKYLKKHAYGNATTDDLWEALQEASGesKPLDVKEIMDSWTL 442
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
153-678 4.60e-126

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 396.32  E-value: 4.60e-126
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  153 RLPTAVVPLRYELSLHPNLTSMTFRGSVTISVQALQVTWN-IILHSTGHNISRVTfmsaVSSQEkqaeiLEYAYHGQ-IA 230
Cdd:COG0308   10 YRPPGYDVTHYDLDLDLDPATTRLSGTATITFTATEAPLDsLVLDLKGLEVTSVT----VDGKP-----LDFTRDGErLT 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  231 IVAPEALLAGHNYTLKIEYSANISSSYYGFYGFSYTDEsneKKYFAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQ 310
Cdd:COG0308   81 ITLPKPLAPGETFTLEIEYSGKPSNGGEGLYRSGDPPD---GPPYLYTQCEPEGARRWFPCFDHPDDKATFTLTVTVPAG 157
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  311 YTALSNMPKKSSVVLDDGLVQDEFSESVKMSTYLVAFIVGEMKNLSQD-VNGTLVSIYAVPEKIGQVHYALETTVKLLEF 389
Cdd:COG0308  158 WVAVSNGNLVSETELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTfASGVPLRVYVRPGLADKAKEAFESTKRMLDF 237
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  390 FQNYFEIQYPLKKLDLVAIPDFEAGAMENWGLLTFREeTLLYDSnTSSMADRKLVTKIIAHELAHQWFGNLVTMKWWNDL 469
Cdd:COG0308  238 FEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGE-KVLADE-TATDADYERRESVIAHELAHQWFGNLVTCADWDDL 315
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  470 WLNEGFATFMEYFSLEKIFKelssyEDFLDARFKTMKK------DSLNSSHPIssSVQSSEQIEEMFDSLSYFKGSSLLL 543
Cdd:COG0308  316 WLNEGFATYMEQLFSEDLYG-----KDAADRIFVGALRsyafaeDAGPNAHPI--RPDDYPEIENFFDGIVYEKGALVLH 388
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  544 MLKTYLSEDVFQHAVVLYLHNHSYASIQSDDLWDSFNEVTNQtlDVKRMMKTWTLQKGFPLVTVQ-----KKGKELFIQQ 618
Cdd:COG0308  389 MLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEASGR--DLSAFFDQWLYQAGLPTLEVEyeydaDGKVTLTLRQ 466
                        490       500       510       520       530       540
                 ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 61742775  619 ERFFlnmkpeiqpsdtSYLWHIPLSY-VTEGRnysKYQSVSLLDKKSGVInlTEEVLWVKV 678
Cdd:COG0308  467 TPPR------------PHPFHIPLEVgLLGGK---LTARTVLLDGEQTEL--VAKPDPVLL 510
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
163-581 2.32e-113

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 355.98  E-value: 2.32e-113
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  163 YELSLHPNLTSMTFRGSVTISVQALQVTWNIILHSTGHNISRVTFMSAvssqeKQAEILEYAYHGQ-IAIVAPEAllAGH 241
Cdd:cd09595    3 YDLDLDVDFTTKTLNGTETLTVDASQVGRELVLDLVGLTIHSVSVNGA-----AVDFGEREHYDGEkLTIPGPKP--PGQ 75
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  242 NYTLKIEYSANISSSYYGFYGFSYTDESnekKYFAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNMPKKS 321
Cdd:cd09595   76 TFTVRISFEAKPSKNLLGWLWEQTAGKE---KPYLFTQFEATHARRIFPCIDHPAVKATFTVTITTPKKDLLASNGALVG 152
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  322 SVVLDDGLVQDEFSESVKMSTYLVAFIVGEMKNLS---QDVNGTLVSIYAVPEKIGQVHYALETTVKLLEFFQNYFEIQY 398
Cdd:cd09595  153 EETGANGRKTYRFEDTPPIPTYLVAVVVGDLEFKYvtvKSQPRVGLSVYSEPLQVDQAQYAFDATRAALAWFEDYFGGPY 232
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  399 PLKKLDLVAIPDFEAGAMENWGLLTFREETLLYDSNTSSmaDRKLVTKIIAHELAHQWFGNLVTMKWWNDLWLNEGFATF 478
Cdd:cd09595  233 PLPKYDLLAVPDFNSGAMENPGLITFRTTYLLRSKVTDT--GARSIENVIAHELAHQWFGNLVTMRWWNDLWLNEGFAVY 310
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  479 MEYFSLEKIFKELSSYEDFLDARFKTMKKDSLNSSHPISSSVQSSEQIEEMFDSLSYFKGSSLLLMLKTYLSEDVFQHAV 558
Cdd:cd09595  311 YENRIMDATFGTSSRHLDQLSGSSDLNTEQLLEDSSPTSTPVRSPADPDVAYDGVTYAKGALVLRMLEELVGEEAFDKGV 390
                        410       420
                 ....*....|....*....|...
gi 61742775  559 VLYLHNHSYASIQSDDLWDSFNE 581
Cdd:cd09595  391 QAYFNRHKFKNATTDDFIDALEE 413
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
378-596 4.40e-105

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 326.55  E-value: 4.40e-105
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    378 YALETTVKLLEFFQNYFEIQYPLKKLDLVAIPDFEAGAMENWGLLTFREETLLYDSNTSSMADRKLVTKIIAHELAHQWF 457
Cdd:pfam01433    1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    458 GNLVTMKWWNDLWLNEGFATFMEYFSLEKIFKELSSYEDF-LDARFKTMKKDSLNSSHPISSSVQSSEQIEEMFDSLSYF 536
Cdd:pfam01433   81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQFlLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                          170       180       190       200       210       220
                   ....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    537 KGSSLLLMLKTYLSEDVFQHAVVLYLHNHSYASIQSDDLWDSFNEVTNqTLDVKRMMKTW 596
Cdd:pfam01433  161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASG-PLDVDSFMDTW 219
M1_APN cd09602
Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the ...
161-588 2.91e-101

Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the catalytic domain of bacterial and eukaryotic aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341065 [Multi-domain]  Cd Length: 440  Bit Score: 324.85  E-value: 2.91e-101
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  161 LRYELSLhpNLTSM--TFRGSVTISVQALQVTWNIILHSTGHNISRVTfmsaVSSQEkqaeiLEYAYHGQIAIVAPEALL 238
Cdd:cd09602   16 VSYDLDL--DLTEGaeTFRGTVTIRFTLREPGASLFLDFRGGEVKSVT----LNGRP-----LDPSAFDGERITLPGLLK 84
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  239 AGHNyTLKIEYSANISSSYYGFYgfSYTDESNEKKYFAaTQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNMP 318
Cdd:cd09602   85 AGEN-TVVVEFTAPYSSDGEGLH--RFVDPADGETYLY-TLFEPDDARRVFPCFDQPDLKATFTLTVTAPADWTVISNGP 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  319 KKSSVVLDDGLVQdEFSESVKMSTYLVAFIVGEMKNLSQDVNGTLVSIYA---VPEKIGQVHYALETTVKLLEFFQNYFE 395
Cdd:cd09602  161 ETSTEEAGGRKRW-RFAETPPLSTYLFAFVAGPYHRVEDEHDGIPLGLYCresLAEYERDADEIFEVTKQGLDFYEDYFG 239
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  396 IQYPLKKLDLVAIPDFEAGAMENWGLLTFREETLLYDSNTSsmADRKLVTKIIAHELAHQWFGNLVTMKWWNDLWLNEGF 475
Cdd:cd09602  240 IPYPFGKYDQVFVPEFNFGAMENPGAVTFRESYLFREEPTR--AQRLRRANTILHEMAHMWFGDLVTMKWWDDLWLNESF 317
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  476 ATFMEYFSLEKIFKELSSYEDFLDARFKT-MKKDSLNSSHPISSSVQSSEQIEEMFDSLSYFKGSSLLLMLKTYLSEDVF 554
Cdd:cd09602  318 ADFMAAKALAEATPFTDAWLTFLLRRKPWaYRADQLPTTHPIAQDVPDLEAAGSNFDGITYAKGASVLKQLVALVGEEAF 397
                        410       420       430
                 ....*....|....*....|....*....|....
gi 61742775  555 QHAVVLYLHNHSYASIQSDDLWDSFNEVTNQTLD 588
Cdd:cd09602  398 RAGLREYFKKHAYGNATLDDLIAALDEASGRDLS 431
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
675-995 2.19e-76

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 253.35  E-value: 2.19e-76
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    675 WVKVNINMNGYYIVHYADDDWEALIHQLkiNPYVLSDKDRANLINNIFELAGLGKVPLKRAFDLINYLGNENHTAPITEA 754
Cdd:pfam11838    1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    755 LFQTDLIYNLLEklgYMDLASRLVTRVFKLLQNQIQQQTWTDEG--TPSMRELRSALLEFACTHNLGNCSTTAMKLFDDW 832
Cdd:pfam11838   79 LSQLSTLRSLLS---ADPEYEALKAFLRKLLSPLAEKLGWEAPPgeSHLDRQLRALLLSAACSAGDPECVAEAKKLFDAW 155
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    833 MasNGTQSLPTDVMTTVFKVGAK--TDKGWSFLLGKYISIGSEAEKNKILEALASSEDVRKLYWLMKSSLNGDNFRTQKL 910
Cdd:pfam11838  156 L--DGDDAIPPDLRWAVYCAAVAngGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDL 233
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    911 SFIIRTVGRHFPGHLLAWDFVKENWNKLVQKFPLGSyTIQNIVAGSTYLFSTKTHLSEVQAFFENQSEATFRlRCVQEAL 990
Cdd:pfam11838  234 RAVIAGLASNPAGRDLAWDFVKENWDALVKRLGGGS-SLGRLVKGLTPSFSTEEELDEVEAFFADKDTPGLR-RALAQAL 311

                   ....*
gi 61742775    991 EVIQL 995
Cdd:pfam11838  312 ETIRR 316
Peptidase_M1_N pfam17900
Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from ...
159-344 1.95e-75

Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from the M1 family.


Pssm-ID: 465557 [Multi-domain]  Cd Length: 186  Bit Score: 245.72  E-value: 1.95e-75
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    159 VPLRYELSLHPNLTSMTFRGSVTISVQALQVTWNIILHSTGHNISRVTFMSAVSSQEKQAEILEYAYHGQ-IAIVAPEAL 237
Cdd:pfam17900    1 VPEHYDLDLKIDLKNFTFSGSVTITLQLNNATNVIVLHASDLTIRSISLSDEVTSDGVPADFTEDQKDGEkLTIVLPETL 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    238 LAGHNYTLKIEYSANISSSYYGFYGFSYTDeSNEKKYFAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNM 317
Cdd:pfam17900   81 NQTGPYTLEIEYSGELNDSMTGFYRSTYTD-NGEKKVLVTTQFEPTDARSAFPCFDEPSVKATFTISIIHPKDYTALSNM 159
                          170       180
                   ....*....|....*....|....*..
gi 61742775    318 PKKSSVVLDDGLVQDEFSESVKMSTYL 344
Cdd:pfam17900  160 PVIASEPLENGWVITTFEQTPKMSTYL 186
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
161-588 3.51e-75

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 253.28  E-value: 3.51e-75
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  161 LRYELSLHPNLTSMTFRGSVTISVQALQVTWNIILHSTGHNISRVTfmsaVSSQEkqAEILEYAYHgQIAIVAPEALLAG 240
Cdd:cd09603    4 LHYDLDLDYDPATKSLSGTATITFRATQDLDSLQLDLVGLTVSSVT----VDGVP--AAFFTHDGD-KLVITLPRPLAAG 76
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  241 HNYTLKIEYSANISSSYYGFYGFSYTDEsneKKYFAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQYTALSNMPKK 320
Cdd:cd09603   77 ETFTVTVRYSGKPRPAGYPPGDGGGWEE---GDDGVWTAGQPEGASTWFPCNDHPDDKATYDITVTVPAGLTVVSNGRLV 153
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  321 SSVVLDDGLVQDEFSESVKMSTYLVAFIVGEMKNLSQD-VNGTLVSIYAVPEKIGQVHYALETTVKLLEFFQNYFeIQYP 399
Cdd:cd09603  154 STTTNGGGTTTWHWKMDYPIATYLVTLAVGRYAVVEDGsGGGIPLRYYVPPGDAAKAKASFARTPEMLDFFEELF-GPYP 232
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  400 LKKLDLVAIPDFEaGAMENWGLLTFREETLLYDSNTSSmadrklvtkIIAHELAHQWFGNLVTMKWWNDLWLNEGFATFM 479
Cdd:cd09603  233 FEKYGQVVVPDLG-GGMEHQTATTYGNNFLNGDRGSER---------LIAHELAHQWFGDSVTCADWADIWLNEGFATYA 302
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  480 EYFSLEKIFKelssyEDFLDARFKTMKKDSLNSSHPISSSVQSseqiEEMFDSLSYFKGSSLLLMLKTYLSEDVFQHAVV 559
Cdd:cd09603  303 EWLWSEHKGG-----ADAYRAYLAGQRQDYLNADPGPGRPPDP----DDLFDRDVYQKGALVLHMLRNLLGDEAFFAALR 373
                        410       420
                 ....*....|....*....|....*....
gi 61742775  560 LYLHNHSYASIQSDDLWDSFNEVTNQTLD 588
Cdd:cd09603  374 AYLARYAHGNVTTEDFIAAAEEVSGRDLT 402
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
216-588 1.02e-71

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 255.10  E-value: 1.02e-71
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    216 KQAEILEYAYHGQIAI--------VAPEALLAGHNyTLKIEYSANISSSYYGFYGFsyTDESNEKKYfAATQFEPLAARS 287
Cdd:TIGR02412   56 LAAQIESVTLNGILDVapvydgsrIPLPGLLTGEN-TLRVEATRAYTNTGEGLHRF--VDPVDGEVY-LYTQFEPADARR 131
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    288 AFPCFDEPAFKATFIIKIIRDEQYTALSNMPKKSSVVLDDGLVQdEFSESVKMSTYLVAFIVGEMKNLSQDVNGTLVSIY 367
Cdd:TIGR02412  132 VFAVFDQPDLKANFKFSVKAPEDWTVISNSRETDVTPEPADRRW-EFPETPKLSTYLTAVAAGPYHSVQDESRSYPLGIY 210
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    368 AVPEKIGQVH--YALETTVKLLEFFQNYFEIQYPLKKLDLVAIPDFEAGAMENWGLLTFREETLLYDSNTSsmADRKLVT 445
Cdd:TIGR02412  211 ARRSLAQYLDadAIFTITRQGLAFFHRKFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAENFLHRAEATR--AEKENRA 288
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    446 KIIAHELAHQWFGNLVTMKWWNDLWLNEGFATFMEYFSLEkifkELSSYEDFLDARFKTMK-----KDSLNSSHPISSSV 520
Cdd:TIGR02412  289 GVILHEMAHMWFGDLVTMRWWNDLWLNESFAEYMGTLASA----EATEYTDAWTTFAAQGKqwayeADQLPTTHPIVADV 364
                          330       340       350       360       370       380
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 61742775    521 QSSEQIEEMFDSLSYFKGSSLLLMLKTYLSEDVFQHAVVLYLHNHSYASIQSDDLWDSFNEVTNQTLD 588
Cdd:TIGR02412  365 ADLADALSNFDGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHAFGNATLDDLIDSLAKASGRDLS 432
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
155-581 6.15e-45

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 168.79  E-value: 6.15e-45
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  155 PTAVVPLRYELSLHPNLTSMTFRGSVTISVQALQVTWN-IILHSTGHNISRVTFmsaVSSQEKQAEILE-YAYHGQ-IAI 231
Cdd:cd09599    8 YDEVRTTHLDLDLTVDFDKKTISGSATLTLEVLQDGADeLVLDTRDLDISSVTV---NGGKELKFELGPrDPVLGSaLTI 84
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  232 VAPEALLAGHNYTLKIEYSANISSSYYGFYGFSYTDEsneKKY-FAATQFEPLAARSAFPCFDEPAFKATFIIKIIRDEQ 310
Cdd:cd09599   85 TLPSPLAKGDTFKVKIEYSTTPQATALQWLTPEQTAG---KKHpYLFTQCQAIHARSLFPCQDTPSVKSTYSATVTVPKG 161
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  311 YTAL-SNMPKKSSVVLDDGLVQdeFSESVKMSTYLVAFIVGEMKnlSQDVnGTLVSIYAVPEKIGQVHYALETTVKLLEF 389
Cdd:cd09599  162 LTALmSALRTGEKEEAGTGTYT--FEQPVPIPSYLIAIAVGDLE--SREI-GPRSGVWAEPSVVDAAAEEFADTEKFLKA 236
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  390 FQNYFeIQYPLKKLDLVAIPD-FEAGAMENwGLLTFREETLLydsntssmA-DRKLVTkIIAHELAHQWFGNLVTMKWWN 467
Cdd:cd09599  237 AEKLY-GPYVWGRYDLLVLPPsFPYGGMEN-PCLTFATPTLI--------AgDRSLVD-VIAHEIAHSWSGNLVTNANWE 305
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  468 DLWLNEGFATFMEYFSLEKIFKElsSYEDFlDA--RFKTMKKD--SLNSSHPISSSVQSSEQI--EEMFDSLSYFKGSSL 541
Cdd:cd09599  306 HFWLNEGFTVYLERRILERLYGE--EYRQF-EAilGWKDLQESikEFGEDPPYTLLVPDLKGVdpDDAFSSVPYEKGFQF 382
                        410       420       430       440
                 ....*....|....*....|....*....|....*....|
gi 61742775  542 LLMLKTYLSEDVFQHAVVLYLHNHSYASIQSDDLWDSFNE 581
Cdd:cd09599  383 LYYLEQLGGREVFDPFLRAYFKKFAFQSIDTEDFKDFLLE 422
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
155-603 7.71e-35

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 141.84  E-value: 7.71e-35
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    155 PTAVVPLRYELSLHPNLTSMTFRGSVTISVQALQVTWNIILHSTGH-NISRVTfmsaVSSQEKQAEILE-YAYHGQ-IAI 231
Cdd:TIGR02411    8 YKDFRTSHTDLNLSVDFTKRKLSGSVTFTLKSLTDNLNKLVLDTSYlDIQKVT----INGLPADFAIGErKEPLGSpLTI 83
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    232 VAPEALLAGHNYTLKIEYSANISSSYYGFYGFSYTDESNEKKYFaaTQFEPLAARSAFPCFDEPAFKATFIIKIirDEQY 311
Cdd:TIGR02411   84 SLPIATSKNDEFVLNISFSTTPKCTALQWLNPEQTSGKKHPYLF--SQCQAIHARSLFPCQDTPSVKSTYTAEV--ESPL 159
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    312 TAL-SNMPKKSSvvlDDGLVQDEFSESVKMSTYLVAFIVGEmknLSQDVNGTLVSIYAVPEKIGQVHYALETTVKllEFF 390
Cdd:TIGR02411  160 PVLmSGIRDGET---SNDPGKYLFKQKVPIPAYLIAIASGD---LASAPIGPRSTVYSEPEQLEKCQYEFENDTE--KFI 231
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    391 QNYFEIQYPL--KKLDLVAIPD-FEAGAMENwGLLTFREETLLydsntssMADRKLVtKIIAHELAHQWFGNLVTMKWWN 467
Cdd:TIGR02411  232 KTAEDLIFPYewGQYDLLVLPPsFPYGGMEN-PNLTFATPTLI-------AGDRSNV-DVIAHELAHSWSGNLVTNCSWE 302
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    468 DLWLNEGFATFME-------YFSLEKIFKELSSYEDfLDARFKTMKKDslnssHPISSSVQSSEQI--EEMFDSLSYFKG 538
Cdd:TIGR02411  303 HFWLNEGWTVYLErriigrlYGEKTRHFSALIGWGD-LQESVKTLGET-----PEFTKLVVDLKDNdpDDAFSSVPYEKG 376
                          410       420       430       440       450       460       470
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775    539 SSLLLMLKTYL-SEDVFQHAVVLYLHNHSYASIQSDDLWDSFNEVTNQTLDVKRM----MKTWTLQKGFP 603
Cdd:TIGR02411  377 FNFLFYLEQLLgGPAEFDPFLRHYFKKFAYKSLDTYQFKDALYEYFKDKKKVDKLdavdWETWLYSPGMP 446
M1_APN cd09600
Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the ...
278-597 8.96e-29

Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. It includes bacterial-type alanyl aminopeptidases as well as PfA-M1 aminopeptidase (Plasmodium falciparum-type). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341063 [Multi-domain]  Cd Length: 434  Bit Score: 120.70  E-value: 8.96e-29
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  278 TQFEPLAARSAFPCFDEPAFKATFIIKIIRD-EQY-TALSNMPKKSSVVLDDGLVQDEFSESVKMSTYLVAFIVGEMKNL 355
Cdd:cd09600  111 TQCEAEGFRRITYFPDRPDVMSKFTVTIEADkEKYpVLLSNGNLIEEGELPNGRHFAVWEDPFPKPSYLFALVAGDLGSV 190
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  356 SQDV---NGTLVS--IYAVPEKIGQVHYALETTVKLLEFFQNYFEIQYPLKKLDLVAIPDFEAGAMENWGLLTFREETLL 430
Cdd:cd09600  191 EDTFttkSGRKVKlrIYVEPGNEDKCHHAMESLKKAMKWDEERFGLEYDLDLFNIVAVDDFNMGAMENKGLNIFNSKYVL 270
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  431 YDSNTSSMADRKLVTKIIAHELAHQWFGNLVTMKWWNDLWLNEGFATFMEY-FS---LEKIFKELSSYEDFLDARFktmK 506
Cdd:cd09600  271 ADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGLTVFRDQeFSadmNSRAVKRIEDVRRLRSAQF---P 347
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  507 KDSLNSSHPISSsvQSSEQIEEMFDSLSYFKGSSLLLMLKTYLSEDVFQHAVVLYLHNHSYASIQSDDLWDSFNEVTNqt 586
Cdd:cd09600  348 EDAGPMAHPIRP--DSYIEINNFYTVTVYEKGAEVIRMLHTLLGEEGFRKGMDLYFERHDGQAVTCEDFVAAMEDASG-- 423
                        330
                 ....*....|.
gi 61742775  587 LDVKRMMKTWT 597
Cdd:cd09600  424 RDLSQFKRWYS 434
M1_APN_like cd09604
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains ...
355-588 1.45e-26

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains bacterial M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341067 [Multi-domain]  Cd Length: 440  Bit Score: 113.91  E-value: 1.45e-26
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  355 LSQDVNGTLVSIYAVPEKIGQVHYALETTVKLLEFFQNYFeIQYPLKKLDLVAiPDFEAGAMEnwglltfrEETLLYDSN 434
Cdd:cd09604  215 DAATVDGVTVNVYYLPENAEAAERALEYAKDALEFFSEKF-GPYPYPELDVVQ-GPFGGGGME--------YPGLVFIGS 284
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  435 TSSMADRKLVTkIIAHELAHQWFGNLVTmkwwND----LWLNEGFATFMEYFSLEKIFKELSSYEDFLDARFKTMKKdsl 510
Cdd:cd09604  285 RLYDPKRSLEG-VVVHEIAHQWFYGIVG----NDerrePWLDEGLATYAESLYLEEKYGKEAADELLGRRYYRAYAR--- 356
                        170       180       190       200       210       220       230
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 61742775  511 NSSHPISSSVQSSEQIEEMFDsLSYFKGSSLLLMLKTYLSEDVFQHAVVLYLHNHSYASIQSDDLWDSFNEVTNQTLD 588
Cdd:cd09604  357 GPGGPINLPLDTFPDGSYYSN-AVYSKGALFLEELREELGDEAFDKALREYYRRYKFKHPTPEDFFRTAEEVSGKDLD 433
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
244-479 3.84e-12

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 69.95  E-value: 3.84e-12
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  244 TLKIEYS-ANISSsyyGFYgFSYTDESNEKKY---FAATQFEPLAARSAFPCFDEPAFKATFIIKII---------RDEQ 310
Cdd:cd09839  135 TIRIEYSlKNPRD---GLH-FVGPDEGGDKRYphvYTTNSPLPGSARCWFPCVDSLWERCTWELEITvprtlgdagRPPL 210
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  311 YTALSNMPKKSSVVLDDG----------LVQDE------------FSESVKMSTYLVAFIVG--EMKNLSQ--------- 357
Cdd:cd09839  211 AGSKEDEDDDDLTEEDKElemvvvcsgdLVEQVvhpedpskktfsFSLSNPTSAQHIGFAVGpfEIVPLPEfreseeddk 290
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775  358 -DVNGTLVSIYAVPEKIGQVHYALETTVKLLEFFQNYFeIQYPLKKLDLV----AIPDFEAGAmenwGLLTFrEETLLYD 432
Cdd:cd09839  291 lGSSAVEVTGFCLPGRLEELRNTCSFLHKAMDFFEEEY-GSYPFSSYKQVfvddLPEDVSSFA----SLSIC-SSRLLYP 364
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....*...
gi 61742775  433 SNtssMADRKL-VTKIIAHELAHQWFGNLVTMKWWNDLWLNEGFATFM 479
Cdd:cd09839  365 PD---IIDQAYeTRRKLAHALASQWFGINIIPKTWSDTWLVIGIAGYM 409
pepN PRK14015
aminopeptidase N; Provisional
366-608 3.41e-07

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 54.37  E-value: 3.41e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775   366 IYAVPEKIGQVHYALETtvklleffqnyfeiqypLKK--------------LDL---VAIPDFEAGAMENWGLLTFREET 428
Cdd:PRK14015  218 IYVEPGNLDKCDHAMDS-----------------LKKsmkwdeerfgleydLDIfmiVAVDDFNMGAMENKGLNIFNSKY 280
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775   429 LLYDSNTSSMADRKLVTKIIAHELAHQWFGNLVTMKWWNDLWLNEGFATF--------MEYFSLEKIfkelssyED--FL 498
Cdd:PRK14015  281 VLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGLTVFrdqefsadLGSRAVKRI-------EDvrVL 353
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 61742775   499 DAR-FktmKKDSLNSSHPIS-SSVQsseqieEM--FDSLS-YFKGSSLLLMLKTYLSEDVFQHAVVLYLHNH--SYASIq 571
Cdd:PRK14015  354 RAAqF---AEDAGPMAHPVRpDSYI------EInnFYTATvYEKGAEVIRMLHTLLGEEGFRKGMDLYFERHdgQAVTC- 423
                         250       260       270
                  ....*....|....*....|....*....|....*..
gi 61742775   572 sDDLWDSFNEVTNQTLDVkrmMKTWTLQKGFPLVTVQ 608
Cdd:PRK14015  424 -EDFVAAMEDASGRDLSQ---FRRWYSQAGTPRVTVS 456
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
408-482 2.50e-06

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 47.09  E-value: 2.50e-06
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 61742775  408 IPDFEAGAMENWGLLTFREETLLydsntssmADRKLVTKIIAHELAHQWFGNLVTMKW-WNDLWLNEGFATFMEYF 482
Cdd:cd09594   37 VEVNAYNAMWIPSTNIFYGAGIL--------DTLSGTIDVLAHELTHAFTGQFSNLMYsWSSGWLNEGISDYFGGL 104
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH